2013. Metabolic Activation and Inactivation of Irinotecan when Combined with the Human Monoclonal Antibody Bevacizumab. Journal of Analytical Oncology. 2, 4 (Dec. 2013),  218–225. DOI:https://doi.org/10.6000/1927-7229.2013.02.04.4.